Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 5
2015 3
2016 5
2017 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Galectin-3 and post-myocardial infarction cardiac remodeling.
Meijers WC, van der Velde AR, Pascual-Figal DA, de Boer RA. Meijers WC, et al. Among authors: van der velde ar. Eur J Pharmacol. 2015 Sep 15;763(Pt A):115-21. doi: 10.1016/j.ejphar.2015.06.025. Epub 2015 Jun 19. Eur J Pharmacol. 2015. PMID: 26101067 Review.
Galectin-3: a modifiable risk factor in heart failure.
de Boer RA, van der Velde AR, Mueller C, van Veldhuisen DJ, Anker SD, Peacock WF, Adams KF, Maisel A. de Boer RA, et al. Among authors: van der velde ar. Cardiovasc Drugs Ther. 2014 Jun;28(3):237-46. doi: 10.1007/s10557-014-6520-2. Cardiovasc Drugs Ther. 2014. PMID: 24789662 Review.
ST2 and Galectin-3: Ready for Prime Time?
Meijers WC, van der Velde AR, de Boer RA. Meijers WC, et al. Among authors: van der velde ar. EJIFCC. 2016 Aug 1;27(3):238-52. eCollection 2016 Aug. EJIFCC. 2016. PMID: 27683537 Free PMC article.
Serial galectin-3 and future cardiovascular disease in the general population.
van der Velde AR, Meijers WC, Ho JE, Brouwers FP, Rienstra M, Bakker SJ, Muller Kobold AC, van Veldhuisen DJ, van Gilst WH, van der Harst P, de Boer RA. van der Velde AR, et al. Heart. 2016 Jul 15;102(14):1134-41. doi: 10.1136/heartjnl-2015-308975. Epub 2016 Apr 15. Heart. 2016. PMID: 27084804 Free PMC article.
Pharmacological inhibition of galectin-3 protects against hypertensive nephropathy.
Frenay AR, Yu L, van der Velde AR, Vreeswijk-Baudoin I, López-Andrés N, van Goor H, Silljé HH, Ruifrok WP, de Boer RA. Frenay AR, et al. Among authors: van der velde ar. Am J Physiol Renal Physiol. 2015 Mar 1;308(5):F500-9. doi: 10.1152/ajprenal.00461.2014. Epub 2014 Dec 10. Am J Physiol Renal Physiol. 2015. PMID: 25503732 Free article.
14 results